MedCity News
MAY 14, 2025
Before health systems can realize more revenue from telemedicine services, they need a technology foundation that enables deeper insights into operations and service expansion. The post Data Integration: The Essential Element in Telemedicine Sustainability appeared first on MedCity News.
PharmaTimes
MAY 14, 2025
Trial progresses towards topline data expected later in the year
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MedCity News
MAY 14, 2025
The real change with AI will happen not when everyone adopts the technology, which is happening quickly, but when these AIs can actually communicate and coordinate with one another. The post The AI Drug Discovery Boom Is Coming. We Are Not Ready. appeared first on MedCity News.
pharmaphorum
MAY 14, 2025
GSK decided to abandon a TIGIT-targeted drug for cancer this week, then hatched a plan to replace it with a candidate for liver disease MASH.
Advertiser: ZoomInfo
AI adoption is reshaping sales and marketing. But is it delivering real results? We surveyed 1,000+ GTM professionals to find out. The data is clear: AI users report 47% higher productivity and an average of 12 hours saved per week. But leaders say mainstream AI tools still fall short on accuracy and business impact. Download the full report today to see how AI is being used — and where go-to-market professionals think there are gaps and opportunities.
MedCity News
MAY 14, 2025
[Sponsored] Megan Zakrewsky, vice president of product at Veradigm talks about how the company is utizing tech among providers, payers and patients. Watch now! The post MedCity Pivot: How Veradigm Aims to Close the Information Gap appeared first on MedCity News.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
MedCity News
MAY 14, 2025
Cohere Health raked in $90 million in Series C capital, taking its total funding to date to $200 million. This round of funding cements Cohere as the emerging winner in the prior authorization tech category, according to Michael Greeley, general partner at Flare Capital Partners. The post Cohere Health Snags $90M to Automate the Much-Maligned Prior Authorization Process appeared first on MedCity News.
pharmaphorum
MAY 14, 2025
Andrew Witty has resigned as CEO of US health conglomerate UnitedHealth, as the company pulled its financial forecasts for 2025.
MedCity News
MAY 14, 2025
GSK is acquiring Boston Pharmaceuticals efimosfermin, which posted Phase 2 results showing improvement in fibrosis and resolution of MASH. GSK said this fusion protein will complement an siRNA drug it is currently developing for liver diseases. The post GSK Makes a Big Liver Disease Move With $1.2B Deal for Phase 3-Ready MASH Drug appeared first on MedCity News.
Pharmaceutical Technology
MAY 14, 2025
Novo Nordisk is doubling down on its oral drug strategy for obesity with a new partnership worth up to $2.2bn with Septerna.
Speaker: Jesse Hunter and Brynn Chadwick
Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.
MedCity News
MAY 14, 2025
Stephen Konya, Chief, Innovation and Strategic Partnerships, ASTP with the Department of Health and Human Services, will speak at INVEST, MedCity’s annual investor conference in Chicago, May 20-21. Register today! The post HHS Health IT Innovation Exec Joins INVEST Agenda at Critical Time for the Department appeared first on MedCity News.
Pharmaceutical Technology
MAY 14, 2025
The deal comes at a time of revival into liver disease treatment investment as market opportunity beckons.
Pharmacy Times
MAY 14, 2025
The announcement came shortly before updated results from the SURMOUNT-5 clinical trial, which found Zepbound had superior weight-loss effects over Wegovy.
PharmExec
MAY 14, 2025
Under the agreement, GSK will acquire BP Asset IX, a subsidiary of Boston Pharmaceuticals, for up to $2 billion in total cash consideration, including $1.2 billion upfront and up to $800 million in milestone payments.
Advertiser: ZoomInfo
ZoomInfo customers aren’t just selling — they’re winning. Revenue teams using our Go-To-Market Intelligence platform grew pipeline by 32%, increased deal sizes by 40%, and booked 55% more meetings. Download this report to see what 11,000+ customers say about our Go-To-Market Intelligence platform and how it impacts their bottom line. The data speaks for itself!
Pharmacy Times
MAY 14, 2025
The FDA approves belzutifan, the first oral treatment for pheochromocytoma and paraganglioma, offering a new treatment pathway for patients with these rare tumors.
PharmExec
MAY 14, 2025
Results from the Phase III REAL8 basket study found that once-weekly Sogroya was effective in children with growth disorders, including those born small for gestational age, with Noonan syndrome, or idiopathic short stature.
Pharmaceutical Technology
MAY 14, 2025
Recipharm has joined forces with ProductLife Group (PLG) to support (bio)pharmaceutical firms in expediting market approval and trial time.
PharmExec
MAY 14, 2025
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Speaker: Kevin Burke
AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.
Pharmacy Times
MAY 14, 2025
Emrelis is a groundbreaking treatment for advanced non-small cell lung cancer, targeting high c-Met protein overexpression.
PharmExec
MAY 14, 2025
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Pharmacy Times
MAY 14, 2025
Like other high-risk groups, children with sickle cell disease have a heightened risk of invasive pneumococcal disease, even if they receive proper pneumococcal conjugate vaccine coverage.
Pharma Marketing Network
MAY 14, 2025
In todays digital-first healthcare landscape, programmatic display ads have become a cornerstone of pharmaceutical marketing strategies. By leveraging automated, data-driven ad placements, pharma brands can reach healthcare professionals (HCPs) and patients with unprecedented precision and efficiency. This guide delves into the essentials of programmatic advertising, its benefits, and best practices for pharma marketers.
Advertiser: ZoomInfo
Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.
Pharmacy Times
MAY 14, 2025
Tirzepatide outperforms semaglutide in weight loss, achieving an average reduction of 20.2% in a pivotal trial for obesity management.
pharmaphorum
MAY 14, 2025
Ursula von der Leyen has lost a lawsuit attempting to force her to disclose text messages with Pfizer's CEO on COVID-19 vaccine procurement
Pharmacy Times
MAY 14, 2025
The seasonal surge in skin irritations underscores the ongoing need for effective and convenient remedies.
MedCity News
MAY 14, 2025
Robert F. Kennedy Jr. testified before the House Committee on Appropriations and the Senate Health, Education, Labor and Pensions Committee on Wednesday. He faced questions on vaccines, HHS cuts and other issues. The post Congress Scrutinizes RFK Jr. on Budget Cuts, Vaccines and More appeared first on MedCity News.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Pharmacy Times
MAY 14, 2025
New trial results reveal icotrokinra's effectiveness in achieving significant skin clearance for challenging scalp and genital psoriasis.
PharmaVoice
MAY 14, 2025
While venture funding is rising, federal policy upheaval may affect women’s health research more acutely than other fields, one biotech CEO said.
Pharmacy Times
MAY 14, 2025
Effectively communicating research findings to patients, health care professionals, and policy payers is necessary for engagement.
Expert insights. Personalized for you.
200 
Let's personalize your content